Tiny URL Website

Patients between 70 and 82 years of age who had a historical past of risk components for vascular disease had been randomized to pravastatin 40 mg/day or placebo. Deep venous thrombosis may be the source of acute pulmonary emboli or result in lengthy-time period venous complications. The patient’s...